Description
CJC-1295 (No DAC)
CJC-1295 without DAC functions by activating the growth hormone releasing hormone (GHRH) receptor, promoting the natural stimulation of growth hormone pathways. Unlike the DAC version, it has a shorter half-life, resulting in more transient elevations of growth hormone in experimental models. Research has explored its potential roles in bone metabolism, lean body mass regulation, glucose handling, and tissue repair. Preclinical studies indicate that CJC-1295 (No DAC) supports pulsatile growth hormone release, which may be beneficial for maintaining natural signaling patterns while achieving targeted outcomes in controlled laboratory settings.







